Now Reading
Biogen Included in 2022 Bloomberg Gender-Equality Index
Biogen Included in 2022 Bloomberg Gender-Equality Index
Published 01-28-22
Submitted by Biogen
We are proud to be included on the Bloomberg Gender Equality Index, a modified market capitalization-weighted index that aims to track the performance of public companies committed to transparency in gender-data reporting.
We recognize the role we play to foster a more inclusive future, including developing the next generation of female leaders at all levels of our organization.
Learn more about our progress in our DE&I report
For more information about Bloomberg’s Gender-Equality Index, please visit: www.bloomberg.com/gei.
Biogen
Biogen
Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease. Biogen is advancing a pipeline of potential novel therapies across neurology, neuropsychiatry, specialized immunology and rare diseases and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.
More from Biogen
